NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Broadwind, Inc.("Broadwind" or the "Company") (NASDAQ:BWEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Broadwind and certain of its officers and/or directors have […]

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Brunello Cucinelli S.p.A. ("Brunello Cucinelli" or the "Company") (OTCMKTS:BCUCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Brunello Cucinelli and certain of its

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Palantir Technologies Inc. ("Palantir" or the "Company") (NASDAQ:PLTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Palantir and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ:VALN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Valneva and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lesaka Technologies, Inc. ("Lesaka" or the "Company") (NASDAQ:LSAK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lesaka and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ:RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Avita and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. ("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CarMax and certain of its officers and/or directors

NEW YORK, NY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ:AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Agios and certain of its officers and/or

NEW YORK, NY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Synopsys and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / October 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. ("Coty" or the "Company") (NYSE:COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Coty and certain of its officers and/or directors